Shang Hai Zheng Quan Bao·2025-12-30 22:44Meeting Overview - The third extraordinary general meeting of shareholders was held on December 30, 2025, at the company's meeting room in Guangzhou, Guangdong Province [2] - The meeting was convened by the board of directors and chaired by Mr. Li Xiaojun, the chairman of the company [2][3] - The voting method combined on-site and online voting, complying with the Company Law and the company's articles of association [2] Attendance - Out of 10 current directors, 9 attended the meeting, with Executive Director Mr. Cheng Hongjin absent due to official duties [3] - The company’s board secretary, Ms. Huang Xuezheng, and other senior management, as well as legal witnesses and vote counters, were present [3] Resolutions - Two ordinary resolutions were passed: 1. Approval for Guangzhou Pharmaceutical Co., Ltd. to conduct accounts receivable asset securitization [4] 2. Approval for the completion of fundraising investment projects and the permanent replenishment of working capital with surplus raised funds [4] - All resolutions received more than half of the votes from the total shares represented at the meeting [5] Legal Witnessing - The meeting was witnessed by Hong Kong Central Securities Depository Co., Ltd., lawyers, and shareholder representatives who acted as vote counters and monitors [5] - The legal opinion was provided by Beijing Zhonglun (Guangzhou) Law Firm, confirming the legality and validity of the meeting's procedures and resolutions [5]